Scarica l'app Stockscreener
20.50
0.24%
-0.05
Dopo l'orario di chiusura:
20.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$20.55
Aprire:
$20.6
Volume 24 ore:
774.70K
Relative Volume:
1.00
Capitalizzazione di mercato:
$1.48B
Reddito:
$434.49M
Utile/perdita netta:
$504.34M
Rapporto P/E:
3.4088
EPS:
6.0138
Flusso di cassa netto:
$181.97M
1 W Prestazione:
-1.16%
1M Prestazione:
-3.98%
6M Prestazione:
-10.83%
1 anno Prestazione:
+16.11%
Intervallo 1D:
$20.50
$20.76
Intervallo di 1 settimana:
$20.50
$21.45
Portata 52W:
$16.52
$25.14
Innoviva Inc Stock (INVA) Company Profile
Nome
Innoviva Inc
Settore
Industria
Telefono
(650) 238-9600
Indirizzo
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA vs VRTX, MRNA, REGN, ARGX, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
20.50 | 1.50B | 434.49M | 504.34M | 181.97M | 6.0138 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-17 | Iniziato | BTIG Research | Buy |
| 2025-09-30 | Iniziato | Goldman | Sell |
| 2025-08-11 | Iniziato | Oppenheimer | Outperform |
| 2025-07-14 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-07-20 | Iniziato | Goldman | Neutral |
| 2017-11-20 | Iniziato | Deutsche Bank | Hold |
Mostra tutto
Innoviva Inc Borsa (INVA) Ultime notizie
Innoviva, Inc. (INVA) Stock Price, News, Quote & History - Yahoo! Finance Canada
THRX5561968 Bond Profile: Coupon and Redemption - TradingView
Innoviva, Inc. (INVA) Stock forecasts - Yahoo Finance Singapore
Innoviva, Inc. (INVA) Stock Forecasts - Yahoo! Finance Canada
Innoviva, Inc. (INVA) Stock Analysis: Exploring a 66.35% Potential Upside in the Biotech Space - directorstalkinterviews.com
(INVA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Price to sales forward of Innoviva, Inc. – NASDAQ:INVA - TradingView
Innoviva at H.C. Wainwright conference: growth shifts to specialty drugs By Investing.com - Investing.com Canada
Understanding Momentum Shifts in (INVA) - Stock Traders Daily
Innoviva at Cantor conference: growth bets beyond COPD royalties By Investing.com - Investing.com Canada
Innoviva at Cantor conference: growth bets beyond COPD royalties - Investing.com
INVA - Finviz
Innoviva to Participate in Upcoming September 2026 Investor Conferences - biospace.com
Innoviva to Participate in Upcoming Investor Conferences - finance.yahoo.com
INVA Q2 2026 Earnings: EPS Misses by 356% as Loss Hits $1.14Consensus Forecast Report - vinanet.vn
(INVA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Entasis Therapeutics Holdings Inc. (ETTX) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Innoviva CEO Pavel Raifeld Executes Tax-Related Share Withholding Transaction - Kalkine Media
Innoviva (NASDAQ: INVA) CFO now holds 88,013 shares after tax withholding - Stock Titan
Cantor Fitzgerald reiterates Innoviva stock rating at overweight By Investing.com - Investing.com Nigeria
Cantor Fitzgerald reiterates Innoviva stock rating at overweight - Investing.com
NewEdge Wealth LLC Acquires New Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. (NASDAQ:INVA) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Innoviva (INVA) Snapshot: Posts a 2.23% Loss to $21.00 in Latest Trading; the Session Ends Within the Reported Technical Boundaries on the DayWedge Breakout - vinanet.vn
70,000 Shares in Innoviva, Inc. $INVA Purchased by Chase Investment Counsel Corp - MarketBeat
Innoviva’s Earnings Swing And Buyback Might Change The Case For Investing In Innoviva (INVA) - simplywall.st
Innoviva, Inc.: Target Price Consensus and Analysts Recommendations | INVA | US45781M1018 - marketscreener.com
Bank of America Corp DE Has $37.75 Million Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva (INVA) Holds Near $20.87 After Modest 0.29% GainSuperTrend - vinanet.vn
Innoviva (INVA) Holds Near $20.81 as Biopharma Royalty Stock Stays RangeboundVolatility Smile - vinanet.vn
HC Wainwright Issues Positive Forecast for Innoviva Earnings - MarketBeat
Three Innoviva therapies named finalists for Prix Galien award By Investing.com - Investing.com Australia
Three Innoviva therapies named finalists for Prix Galien award - Investing.com
Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award - Business Wire
Innoviva, Inc. (INVA) Stock Analysis: Uncovering a 69% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
How (INVA) Movements Inform Risk Allocation Models - Stock Traders Daily
Innoviva (INVA) Holds Steady at $20.68: Key Support and Resistance in FocusJelly Roll Trade - dars.gov.et
Does Innoviva’s Q2 Loss and Buyback-Fueled EPS Shift Change The Bull Case For INVA? - webull.com
Innoviva stock price target reiterated at $46 by H.C. Wainwright - Investing.com Nigeria
Innoviva Stock Price Forecast. Should You Buy INVA? - StockInvest.us
Innoviva Inc (INVA) Stock News Today - TradingKey
How Innoviva’s Q2 Loss and Aggressive Buybacks Could Reshape Capital Allocation for INVA Investors - Yahoo Finance
Innoviva Inc (INVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $34 - Moomoo
Innoviva (INVA) Stock Can Revenue Growth Offset A Sharp Profit Reversal - webull.com
Cantor Fitzgerald Lowers Innoviva (NASDAQ:INVA) Price Target to $34.00 - MarketBeat
Innoviva (INVA) Slips 2.2% as Shares Approach Key Support at $19.61ETF Creation Redemption - dars.gov.et
Innoviva: The Royalty Decline Is Real, But The Valuation Is Too Pessimistic (NASDAQ:INVA) - Seeking Alpha
BTIG Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $42 - Moomoo
Innoviva (NASDAQ:INVA) Announces Quarterly Earnings Results, Misses Expectations By $1.58 EPS - MarketBeat
Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva Inc Azioni (INVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):